APA (7th ed.) Citation

Martin, A., Smith, D. E., Carr, A., Ringland, C., Amin, J., Emery, S., . . . Cooper, D. A. (2004). Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: The MITOX Extension Study. AIDS (London), 18(7), 1029-1036. https://doi.org/10.1097/00002030-200404300-00011

Chicago Style (17th ed.) Citation

Martin, Allison, et al. "Reversibility of Lipoatrophy in HIV-infected Patients 2 Years After Switching from a Thymidine Analogue to Abacavir: The MITOX Extension Study." AIDS (London) 18, no. 7 (2004): 1029-1036. https://doi.org/10.1097/00002030-200404300-00011.

MLA (9th ed.) Citation

Martin, Allison, et al. "Reversibility of Lipoatrophy in HIV-infected Patients 2 Years After Switching from a Thymidine Analogue to Abacavir: The MITOX Extension Study." AIDS (London), vol. 18, no. 7, 2004, pp. 1029-1036, https://doi.org/10.1097/00002030-200404300-00011.